ZNF217 and breast cancer: Finally, high ZNF217 mRNA (univariate analysis, p = 0.02, p = 0.011, p = 0.047, p = 0.035) or protein levels (p = 0.05) in human ER+ primary breast cancer tumors were predictors of earlier relapse under endocrine therapy only (Table 1) [51].